These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 10611136)
21. In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene. Taavitsainen P; Juvonen R; Pelkonen O Drug Metab Dispos; 2001 Mar; 29(3):217-22. PubMed ID: 11181487 [TBL] [Abstract][Full Text] [Related]
22. Interindividual variability of coumarin 7-hydroxylation in healthy volunteers. Rautio A; Kraul H; Kojo A; Salmela E; Pelkonen O Pharmacogenetics; 1992 Oct; 2(5):227-33. PubMed ID: 1306122 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of coumarin derivatives as selective CYP2A6 inhibitors. Yamaguchi Y; Nishizono N; Kobayashi D; Yoshimura T; Wada K; Kobayashi K; Oda K Bioorg Med Chem Lett; 2023 Apr; 86():129206. PubMed ID: 36889653 [TBL] [Abstract][Full Text] [Related]
24. Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6. Hadidi H; Irshaid Y; Vågbø CB; Brunsvik A; Cholerton S; Zahlsen K; Idle JR Eur J Clin Pharmacol; 1998 Jul; 54(5):437-41. PubMed ID: 9754990 [TBL] [Abstract][Full Text] [Related]
25. CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients. Sotaniemi EA; Rautio A; Bäckstrom M; Arvela P; Pelkonen O Br J Clin Pharmacol; 1995 Jan; 39(1):71-6. PubMed ID: 7756103 [TBL] [Abstract][Full Text] [Related]
26. An inhibitory monoclonal antibody to human cytochrome P450 2A6 defines its role in the metabolism of coumarin, 7-ethoxycoumarin and 4-nitroanisole in human liver. Sai Y; Yang TJ; Krausz KW; Gonzalez FJ; Gelboin HV Pharmacogenetics; 1999 Apr; 9(2):229-37. PubMed ID: 10376770 [TBL] [Abstract][Full Text] [Related]
27. Induction of cytochrome P450 2A6 expression in humans by the carcinogenic parasite infection, opisthorchiasis viverrini. Satarug S; Lang MA; Yongvanit P; Sithithaworn P; Mairiang E; Mairiang P; Pelkonen P; Bartsch H; Haswell-Elkins MR Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):795-800. PubMed ID: 8896890 [TBL] [Abstract][Full Text] [Related]
28. Effect of cigarette smoking on coumarin metabolism in humans. Poland RE; Pechnick RN; Cloak CC; Wan YJ; Nuccio I; Lin KM Nicotine Tob Res; 2000 Nov; 2(4):351-4. PubMed ID: 11197315 [TBL] [Abstract][Full Text] [Related]
29. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4. Spracklin DK; Thummel KE; Kharasch ED Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607 [TBL] [Abstract][Full Text] [Related]
31. Diversity of selective environmental substrates for human cytochrome P450 2A6: alkoxyethers, nicotine, coumarin, N-nitrosodiethylamine, and N-nitrosobenzylmethylamine. Le Gal A; Dréano Y; Lucas D; Berthou F Toxicol Lett; 2003 Sep; 144(1):77-91. PubMed ID: 12919726 [TBL] [Abstract][Full Text] [Related]
32. Variation in coumarin 7-hydroxylase activity associated with genetic polymorphism of cytochrome P450 2A6 and the body status of iron stores in adult Thai males and females. Ujjin P; Satarug S; Vanavanitkun Y; Daigo S; Ariyoshi N; Yamazaki H; Reilly PE; Moore MR; Kamataki T Pharmacogenetics; 2002 Apr; 12(3):241-9. PubMed ID: 11927840 [TBL] [Abstract][Full Text] [Related]
33. Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice. Takeuchi H; Saoo K; Yokohira M; Ikeda M; Maeta H; Miyazaki M; Yamazaki H; Kamataki T; Imaida K Cancer Res; 2003 Nov; 63(22):7581-3. PubMed ID: 14633670 [TBL] [Abstract][Full Text] [Related]
34. Effects of chronic exposure to low-level cadmium on renal tubular function and CYP2A6-mediated coumarin metabolism in healthy human subjects. Satarug S; Nishijo M; Ujjin P; Vanavanitkun Y; Baker JR; Moore MR Toxicol Lett; 2004 Mar; 148(3):187-97. PubMed ID: 15041069 [TBL] [Abstract][Full Text] [Related]
35. A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin. Hadidi H; Zahlsen K; Idle JR; Cholerton S Food Chem Toxicol; 1997 Sep; 35(9):903-7. PubMed ID: 9409631 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of nicotine metabolism by methoxysalen: Pharmacokinetic and pharmacological studies in mice. Damaj MI; Siu EC; Sellers EM; Tyndale RF; Martin BR J Pharmacol Exp Ther; 2007 Jan; 320(1):250-7. PubMed ID: 17021260 [TBL] [Abstract][Full Text] [Related]
38. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis. Kharasch ED; Walker A; Hoffer C; Sheffels P Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460 [TBL] [Abstract][Full Text] [Related]
39. Evidence for metabolic activation of N'-nitrosonornicotine and N-nitrosobenzylmethylamine by a rat nasal coumarin hydroxylase. Patten CJ; Peterson LA; Murphy SE Drug Metab Dispos; 1998 Feb; 26(2):177-80. PubMed ID: 9456305 [TBL] [Abstract][Full Text] [Related]
40. Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes. Mäenpää J; Sigusch H; Raunio H; Syngelmä T; Vuorela P; Vuorela H; Pelkonen O Biochem Pharmacol; 1993 Mar; 45(5):1035-42. PubMed ID: 8461033 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]